Skip to main content

Study on the relationship between obesity and complications of Pediatric Epilepsy surgery

Abstract

Objective

Studies have shown that obesity has a significant impact on poor surgical outcomes. However, the relationship between obesity and pediatric epilepsy surgery has not been reported. This study aimed to explore the relationship between obesity and complications of pediatric epilepsy surgery and the effect of obesity on the outcome of pediatric epilepsy surgery, and to provide a reference for weight management of children with epilepsy.

Methods

A single-center retrospective analysis of complications in children undergoing epilepsy surgery was conducted. Body mass index (BMI) percentiles were adjusted by age and used as a criterion for assessing obesity in children. According to the adjusted BMI value, the children were divided into the obese group (n = 16) and nonobese group (n = 20). The intraoperative blood loss, operation time, and postoperative fever were compared between the two groups.

Results

A total of 36 children were included in the study, including 20 girls and 16 boys. The mean age of the children was 8.0 years old, ranging from 0.8 to 16.9 years old. The mean BMI was 18.1 kg/m2, ranging from 12.4 kg/m2 to 28.3 kg/m2. Sixteen of them were overweight or obese (44.4%). Obesity was associated with higher intraoperative blood loss in children with epilepsy (p = 0.04), and there was no correlation between obesity and operation time (p = 0.21). Obese children had a greater risk of postoperative fever (56.3%) than nonobese children (55.0%), but this was statistically nonsignificant (p = 0.61). The long-term follow-up outcomes showed that 23 patients (63.9%) were seizure-free (Engel grade I), 6 patients (16.7%) had Engel grade II, and 7 patients (19.4%) had Engel grade III. There was no difference in long-term seizure control outcomes between obese and nonobese groups (p = 0.682). There were no permanent neurological complications after surgery.

Conclusion

Compared with nonobese children with epilepsy, obese children with epilepsy had a higher intraoperative blood loss. It is necessary to conduct early weight management of children with epilepsy as long as possible.

Peer Review reports

Background

Epilepsy is one of the most common disabling chronic neurological diseases [1]. Despite the availability of over 20 antiepileptic drugs (AEDs) for the symptomatic treatment of epilepsy, approximately one-third of patients with epilepsy have epilepsy refractory to AEDs [2]. It is generally acknowledged that epilepsy surgery and neuromodulation surgery are effective therapies to treat refractory epilepsy [3, 4]. Recent studies have shown that neurostimulation has also become one of the effective therapies for refractory epilepsy [5, 6].

Childhood obesity is one of the primary public health problems faced by children [7]. Recent surveys show that 17.1% of children have obesity, with an increasing obesity rate of children [8, 9]. Obesity is particularly common in children with epilepsy due to the side effects of AEDs [10, 11]. It has been reported that 38.6% of children with epilepsy are overweight or obese, of which 19.9% are obese and 18.7% are overweight [12].

Studies have shown that obesity is one of the important risk factors for poor surgical outcomes, which may be related to prolonged operation time, poor wound healing, and comorbidities in obese patients [13,14,15,16]. However, the relationship between obesity and pediatric epilepsy surgery has not been reported. By reviewing the cases of children with refractory epilepsy, this study discussed the relationship between obesity and complications of pediatric epilepsy surgery with refractory epilepsy and the effect of obesity on the outcome of pediatric epilepsy surgery, and provided a reference for weight management of children with epilepsy.

Methods

Case selection

Data from patients with refractory focal epilepsy who underwent epilepsy surgery in Wuhan Children’s Hospital from January 2017 to October 2021 were collected. Epilepsy surgery included temporal lobectomy, selective amygdalohippocampectomy, selective amygdalohippocampotomy, frontal lobotomy, and hemispherotomy. Inclusion criteria included the following: (1) Patients were diagnosed with refractory focal epilepsy. (2) The patients were younger than 18 years old at surgery. Exclusion criteria included the following: (1) The necessary clinical data of cases were incomplete, including the height and weight of patients. (2) The presence of intraoperative blood loss and postoperative fever could not be determined or recorded.

Extraction of clinical data

The clinical data, including demographic characteristics, operation time, intraoperative blood loss, and postoperative fever, were extracted from electronic health records. The amount of intraoperative blood loss was measured by the suction device: the container of the suction device had a scale to measure the amount of imbibition. Meanwhile, the amount of saline used for intraoperative irrigation was also recorded. Then the difference between the amount of imbibition in the container of the suction device and the amount of saline was considered as the amount of intraoperative blood loss. The measurements of height and weight were as follows. For children up to 2 years old, a length measuring device was used to measure length as height and a horizontal baby electronic scale was used to measure weight. For children over 2 years old, a standing height meter was used to measure height and a vertical weight scale was used to measure weight.

The formula for calculating body mass index (BMI) was BMI = weight/height2. BMI percentiles adjusted for age were used as a criterion for assessing obesity in children [17]. As a secondary response, BMI percentiles were classified into the following categories: (1) obese: The BMI was ≥ the 85th percentile for age, (2) overweight: The BMI was more than 85th percentile and less than the 95th percentile for age, (3) nonobese: The BMI was<the 85th percentile for age. In order to facilitate the comparison and analysis, cases were divided into an obese group (obese or overweight cases) and a nonobese group (nonobese cases) by BMI percentiles.

Follow-up

Follow-up methods mainly included outpatient follow-up and telephone follow-up. All patients were followed up for at least 12 months. Postoperative epilepsy control was assessed by Engel classification.

Statistical analysis

Descriptive statistics were used to describe the group characteristics of children. Continuous variables included the following: The D’Agostino-Pearson normality test was used to assess whether the intraoperative blood loss followed a normal distribution, and the unpaired t-test was used to compare whether there was a difference in intraoperative blood loss between obese and nonobese groups. The mean ± standard deviation and 95% confidence intervals (CIs) were used to measure the size of the difference between groups. Discrete variables included the following: Fisher’s exact test was used to compare whether there was a difference in the incidence of postoperative fever between obese and nonobese groups. All tests were 2-sided and used a 0.05 significance level.

Results

Clinical data

A total of 36 cases were included in the study. The clinical data of the children are shown in Table 1, including 20 male children and 16 female children. The mean age of the children was 8.0 years old, ranging from 0.8 to 16.9 years old. The mean BMI was 18.1 kg/m2, ranging from 12.4 kg/m2 to 28.3 kg/m2. Five patients were overweight (13.9%), and 11 patients were obese (30.6%). The epilepsy surgeries included temporal lobectomy (n = 5), selective amygdalohippocampectomy (n = 6), selective amygdalohippocampotomy (n = 8), frontal lobotomy (n = 2) and hemispherotomy (n = 15), with no significant difference in the distribution between groups (p = 0.91). There were no wound complications in two groups.

Table 1 Clinical data of the collected cases. SAHC: Selective Amygdalohippocampectomy; SAHCo: Selective Amygdalohippocampotomy

Obesity and intraoperative blood loss

The mean intraoperative blood loss in the obese group was 173.3 ± 96.1 ml, ranging from 56.0 to 397.0 ml. The mean intraoperative blood loss in the nonobese group was 104.3 ± 58.6 ml, ranging from 22.0 to 208.0 ml. The D’Agostino-Pearson normality test showed that the data in both groups followed a normal distribution (obese group: p = 0.15; nonobese group: p = 0.44). The mean difference between the two groups was 69.1 ± 32.0 ml, 95% CI: 3.0-135.1 ml. The results of the unpaired t-test showed that the difference was statistically significant (p = 0.04) (Fig. 1).

Fig. 1
figure 1

 A violin diagram showed that the overall distribution of the obese and nonobese groups was similar, and the intraoperative blood loss in the obese group was higher than that in the nonobese group

Obesity and operation time of children

The mean operation time of the obese group was 171.7 ± 69.2 min, ranging from 63.0 to 294.0 min. The mean operation time in the nonobese group was 200.6 ± 47.4 min, ranging from 155.0 to 303.0 min. The D’Agostino-Pearson normality test showed that the two groups of data followed a normal distribution (obese group: p = 0.69; nonobese group: p = 0.31). The mean difference between the two groups was 29.0 ± 22.9 min, 95% CI: 18.1–76.0 min. Unpaired t-test results showed that the difference was not statistically significant (p = 0.22) (Fig. 2).

Fig. 2
figure 2

 A violin diagram showed that the overall distribution of obese and nonobese groups was similar, and there was no significant difference between the two groups

Obesity and postoperative fever in children

According to the occurrence time of postoperative fever, postoperative fever was divided into four groups: no fever, early postoperative fever (0–2 days), middle postoperative fever (3–6 days), and late postoperative fever (7–10 days).

The incidence of postoperative fever of patients was shown in Table 1. A total of 20 patients (55.6%) had a postoperative fever, 9 (56.3%) in the obese group and 11 (55.0%) in the nonobese group. Among them, 8 patients had an early postoperative fever, 5 in the obese group and 3 in the nonobese group; 4 patients had a middle postoperative fever, 1 in the obese group and 3 in the nonobese group; and 8 patients had a late postoperative fever, 3 in the obese group and 5 in the nonobese group. The obese group had a higher incidence of postoperative fever than the nonobese group, but Fisher’s exact test showed that obesity was not significantly associated with postoperative fever (p = 0.61) (Fig. 3).

Fig. 3
figure 3

Interleaved bars showed that the obese group had a higher incidence of postoperative fever than the nonobese group

Follow-up

The mean follow-up time of the patients was 20 months, ranging from 12 to 48 months. The long-term follow-up outcomes showed that 23 patients (63.9%) were seizure-free (Engel grade I), 6 patients (16.7%) had Engel grade II, and 7 patients (19.4%) had Engel grade III. In the obese group, 10 patients had Engel grade I, 2 had Engel grade II, and 4 had Engel grade III. Meanwhile, 13 patients had Engel grade I, 4 had Engel grade II, and 3 had Engel grade III in the nonobese group. There was no difference in long-term seizure control outcomes between obese and nonobese groups (p = 0.682). In addition, there were no long-term neurological complications after surgery, such as aphasia and hemiplegia.

Discussion

Obesity and epilepsy

It has been reported that 38.6% of children with epilepsy are overweight or obese, of which 19.9% ​​are obese and 18.7% are overweight, more than double the proportion of children expected to be overweight in a normal population [12]. Due to the side effects of AEDs such as valproic acid, carbamazepine, and gabapentin, taking AEDs may lead to obesity in children. At the same time, obesity in children can also lead to a decrease in their medication compliance, which further leads to poor epilepsy control [18,19,20]. Among the cases included in our study, 13.9% were overweight and 30.6% were obese, which is consistent with Daniels’ results [12]. Regardless, it is necessary to conduct early control and treatment of epilepsy in children in time and to control the weight of children with epilepsy as long as possible.

Obesity and intraoperative blood loss and operation time

Studies have shown that obesity is a risk factor for poor surgical outcomes [13,14,15,16]. Obesity is an independent risk factor for prolonged operation time and room time [21], postoperative thrombotic complications [22], atrial arrhythmias [23, 24], and wound infection [25].

We found that the mean intraoperative blood loss in the obese group was significantly higher than that in the nonobese group (p = 0.04). Tjeertes found higher intraoperative blood loss in obese patients, possibly because obese patients had more difficulty in exposing and dissecting the surgical site, requiring more tissue to be cut, prolonging operation time, and increasing intraoperative blood loss [26]. The operation time may change according to surgical technique and practitioner. In our study, all epilepsy surgeries were performed by the same neurosurgeon, and there was no difference in the distribution of different epilepsy surgeries among the cases according to Table 1(p = 0.91), so the possible influence of surgical technique and practitioner on the operation time could be excluded to some extent. However, our study found no significant difference in operation time between obese and nonobese groups (p = 0.22), suggesting that the length of operation time was not responsible for the difference in intraoperative blood loss between the obese and nonobese groups. Similarly, the possible influence of age and surgical technique on intraoperative blood loss could be partially excluded.

Furthermore, coagulopathies, especially thrombocytopenia, are considered as the side effects of some AEDs so that patients on these AEDs might have a bleeding tendency. Gerstner found that valproate-associated coagulopathies were frequent and variable in children [27]. Another study showed that valproic acid was associated with a decreased platelet count, although thrombocytopoiesis is not affected, even in children with a reduced platelet count [28]. Carbamazepine was also thought to cause thrombocytopenia besides valproic acid through an autoimmune mechanism [29, 30]. Based on the NICE guideline [NG217] (https://www.nice.org.uk/guidance/ng217), lamotrigine and levetiracetam were considered as the first-line AEDs for focal epilepsy rather than valproic acid. For patients with refractory focal epilepsy in our study, we usually used a first-line AED combined with one of oxcarbazepine, perampanel, and nitrazepam according to the patient’s specific condition. If the patient was on valproic acid before being hospitalized, it would be stopped and be switched to oxcarbazepine for at least one week before the surgery.

In addition, there may be another reason that adipose tissue in obese children mainly accumulates in the trunk and limbs, while the epilepsy surgery site is in the brain, and there is little fat accumulation at the surgery site. Therefore, for children with epilepsy, higher intraoperative blood loss in the obese group may not be associated with operation time. Some studies have found that obese patients have a hyperactive inflammatory response, increased angiogenesis in the tissue compared with nonobese patients, a more abundant blood supply in the tissue, a higher bleeding risk, and a higher amount of intraoperative blood loss [31,32,33].

Obesity and postoperative fever

Fever is one of the most common postoperative complications of surgery. According to the cause of fever, postoperative fever can be divided into infectious fever and non-infectious fever. Non-infectious fevers are in turn associated with trauma and inflammation from the surgery, suture foreign body reactions, transfusion reactions, and drug-induced fevers [34, 35]. According to the time postoperative fever occurs, postoperative fever can be divided into early postoperative fever (0–2 days), middle postoperative fever (3–6 days) and late postoperative fever (7–10 days).

A total of 20 patients (55.6%) had a postoperative fever, 9 patients (56.3%) in the obese group and 11 (55.0%) in the nonobese group. The incidence in the obese group was slightly higher than that in the nonobese group, and the obese group tended to have early postoperative fever, while the nonobese group was more likely to have middle-late postoperative fever; however, the statistical results showed no significant correlation between obesity and postoperative fever (p = 0.61). There was no difference in postoperative fever between obese and nonobese groups in our study. The possible reason is that the type of postoperative fever in the children was mainly non-infectious fever caused by surgical trauma.

It has been reported that obese patients have lower immunity and are more likely to have postoperative infectious fever [36,37,38]. Meanwhile, obesity has been found to be associated with altered collagen structure and resistance to leptin, leading to impaired wound healing [39]. However, all cases included in our study had good postoperative wound healing and no intracranial infection, which means that postoperative fever was not associated with surgical site infection.

Intraventricular blood loss after neurosurgery is a recognized reason for aseptic meningitis and non-infectious fever [40]. There was a significant difference in intraoperative blood loss between obese and nonobese groups in our study, while no significant difference was found in the incidence of postoperative fever between the two groups. Almeida found that ventriculotomy is not an independent cause of fever after hemispherectomy [41], probably because intraventricular blood loss after ventriculotomy can be well managed and an insufficient amount of blood remains to cause a postoperative fever.

Limitations

This study still has some limitations. First, this study was a retrospective study and it was subject to inherent bias in the study design. Also, epilepsy surgery has different surgical approaches depending on the etiology and localization of epileptogenic foci, and it is difficult to determine whether different surgical approaches will affect intraoperative blood loss and postoperative fever. In addition, the sample size of cases and observation indicators included in this study were small. Considering that the immune system of children has not yet been established, they are more likely to have a fever with unknown causes. Prospective studies with larger sample sizes are still required to further explore the relationship between obesity and epilepsy surgical complications in children.

Conclusion

This study investigated the relationship between obesity and intraoperative blood loss and postoperative fever in children with refractory epilepsy. Compared with nonobese cases, obese cases had higher intraoperative blood loss during surgery. Obesity was not associated with postoperative fever or operation time. It is necessary to conduct early weight management of children with epilepsy as long as possible. Due to the small sample size of cases and limited observation indicators included in this study, the relationship between obesity and complications of pediatric epilepsy surgery still needs to be further explored.

Data availability

The clinical data of patients in the current study were extracted from electronic health records in the medical record system of Wuhan Children’s Hospital. The clinical data could be obtained through Dr. Ruan at Wuhan Children’s Hospital.

References

  1. Devinsky O, Vezzani A, O’Brien TJ, Jette N, Scheffer IE, de Curtis M et al. Epilepsy. NAT REV DIS PRIMERS. [Journal Article; Review]. 2018 2018-06-07;4(1):18024.

  2. Löscher W, Potschka H, Sisodiya SM, Vezzani A. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options. PHARMACOL REV. [Journal Article; Research Support, Non-U.S. Gov’t; Review]. 2020 2020-07-01;72(3):606–38.

  3. Thijs RD, Surges R, O’Brien TJ, Sander JW. Epilepsy in adults. The Lancet. [Journal Article; Review]. 2019 2019-02-16;393(10172):689–701.

  4. Huang H, Chen L, Chopp M, Young W, Robert Bach J, He X, et al. The 2020 yearbook of Neurorestoratology. J Neurorestoratology [Review]. 2021;9(1):1–12.

    Article  Google Scholar 

  5. Qin X, Lin S, Yuan Y, Wen J, Chen Q, Lu X, et al. Vagus nerve stimulation for pediatric patients with drug-resistant epilepsy caused by genetic mutations: two cases. J Neurorestoratology [Article]. 2020;8(3):138–48.

    Article  Google Scholar 

  6. Yang Z, Zhang C, Wang Z, Cheng T, Qin X, Deng J, et al. Vagal nerve stimulation is effective in pre-school children with intractable epilepsy: a report of two cases. J Neurorestoratology [Article]. 2020;8(3):149–59.

    Article  CAS  Google Scholar 

  7. Smith JD, Fu E, Kobayashi MA. Prevention and Management of Childhood Obesity and Its Psychological and Health Comorbidities. ANNU REV CLIN PSYCHO. [Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov’t, P.H.S.; Review]. 2020 2020-05-07;16(1):351–78.

  8. O Connor EA, Evans CV, Burda BU, Walsh ES, Eder M, Lozano P. Screening for Obesity and Intervention for Weight Management in Children and Adolescents. JAMA. [Journal Article; Review; Systematic Review]. 2017 2017-06-20;317(23):2427.

  9. Bleich SN, Vercammen KA, Zatz LY, Frelier JM, Ebbeling CB, Peeters A. Interventions to prevent global childhood overweight and obesity: a systematic review.The Lancet Diabetes & Endocrinology. [Journal Article; Review; Systematic Review]. 2018 2018-04-01;6(4):332–46.

  10. Aaberg KM, Bakken IJ, Lossius MI, Lund Søraas C, Håberg SE, Stoltenberg C et al. Comorbidity and Childhood Epilepsy: A Nationwide Registry Study. PEDIATRICS. [Journal Article; Research Support, Non-U.S. Gov’t]. 2016 2016-09-01;138(3).

  11. Im DU, Kim SC, Chau GC, Um SH. Carbamazepine Enhances Adipogenesis by Inhibiting Wnt/β-catenin Expression. Cells (Basel, Switzerland). [Journal Article; Research Support, Non-U.S. Gov’t]. 2019 2019-01-01;8(11):1460.

  12. Daniels ZS, Nick TG, Liu C, Cassedy A, Glauser TA. Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy. NEUROLOGY. [Journal Article; Research Support, N.I.H., Extramural]. 2009 2009-09-01;73(9):658–64.

  13. Abdelrahman T, Latif A, Chan DS, Jones H, Farag M, Lewis WG et al. Outcomes after laparoscopic anti-reflux surgery related to obesity: A systematic review and meta-analysis.INT J SURG. [Journal Article; Meta-Analysis; Review; Systematic Review]. 2018 2018-03-01;51:76–82.

  14. Byrne JJ, Smith EM, Saucedo AM, Doody KA, Holcomb DS, Spong CY. Examining the Association of Obesity With Postpartum Tubal Ligation. Obstetrics & Gynecology. [Journal Article]. 2020 2020-08-01;136(2):342–8.

  15. Gaulton TG, Fleisher LA, Neuman MD. The association between obesity and disability in survivors of joint surgery: analysis of the health and retirement study.BRIT J ANAESTH. [Journal Article]. 2018 2018-01-01;120(1):109–16.

  16. Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. NAT REV GASTRO HEPAT. [Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov’t]. 2017 2017-02-01;14(2):110–21.

  17. CDC. Overweight & Obesity: Defining Childhood Weight Status. https://www.cdc.gov/obesity/basics/childhood-defining.html. Accessed 9 Feb 2023.

  18. Al-Faris EA, Abdulghani HM, Mahdi AH, Salih MA, Al-Kordi AG. Compliance with appointments and medications in a pediatric neurology clinic at a University Hospital in Riyadh, Saudi Arabia. SAUDI MED J. [Journal Article]. 2002 2002-08-01;23(8):969–74.

  19. Chukwu J, Delanty N, Webb D, Cavalleri GL. Weight change, genetics and antiepileptic drugs. Expert Rev Clin Pharmacol [Journal Article; Review]. 2014;2014–01–01(1):43–51.

    Article  Google Scholar 

  20. Kim DW, Yoo MW, Park KS. Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients. EPILEPSY BEHAV. [Journal Article; Research Support, Non-U.S. Gov’t]. 2012 2012-04-01;23(4):497–9.

  21. Gholson JJ, Shah AS, Gao Y, Noiseux NO. Morbid Obesity and Congestive Heart Failure Increase Operative Time and Room Time in Total Hip Arthroplasty.The Journal of Arthroplasty. [Journal Article]. 2016 2016-04-01;31(4):771–5.

  22. Sloan M, Sheth N, Lee G. Is Obesity Associated With Increased Risk of Deep Vein Thrombosis or Pulmonary Embolism After Hip and Knee Arthroplasty? A Large Database Study. Clinical Orthopaedics & Related Research. [Journal Article]. 2019 2019-03-01;477(3):523–32.

  23. Perrier S, Meyer N, Hoang Minh T, Announe T, Bentz J, Billaud P et al. Predictors of Atrial Fibrillation After Coronary Artery Bypass Grafting: A Bayesian Analysis. The Annals of Thoracic Surgery. [Journal Article; Observational Study]. 2017 2017-01-01;103(1):92–7.

  24. Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis. J AM COLL CARDIOL. [Journal Article; Review]. 2017 2017-10-17;70(16):2022–35.

  25. O Byrne ML, Kim S, Hornik CP, Yerokun BA, Matsouaka RA, Jacobs JP et al. Effect of Obesity and Underweight Status on Perioperative Outcomes of Congenital Heart Operations in Children, Adolescents, and Young Adults. CIRCULATION. [Journal Article; Multicenter Study]. 2017 2017-08-22;136(8):704–18.

  26. Tjeertes EEKM, Hoeks SSE, Beks SSBJ, Valentijn TTM, Hoofwijk AAGM, Stolker RJRJ. Obesity – a risk factor for postoperative complications in general surgery? BMC ANESTHESIOL. [Journal Article]. 2015 2015-07-31;15(1):112.

  27. Gerstner T, Teich M, Bell N, Longin E, Dempfle CE, Brand J et al. Valproate-associated coagulopathies are frequent and variable in children. EPILEPSIA. [Case Reports; Comparative Study; Journal Article]. 2006 2006-07-01;47(7):1136–43.

  28. Kurahashi H, Takami A, Murotani K, Numoto S, Okumura A. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.INT J HEMATOL. [Journal Article]. 2018 2018-01-01;107(1):105–11.

  29. Kumar R, Chivukula S, Katukuri GR, Chandrasekhar UK, Shivashankar KN. Carbamazepine Induced Thrombocytopenia.J Clin Diagn Res. [Case Reports]. 2017 2017-09-01;11(9):D12-3.

  30. Verrotti A, Scaparrotta A, Grosso S, Chiarelli F, Coppola G. Anticonvulsant drugs and hematological disease.NEUROL SCI. [Journal Article; Review]. 2014 2014-07-01;35(7):983–93.

  31. Hammarstedt A, Gogg S, Hedjazifar S, Nerstedt A, Smith U. Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity. PHYSIOL REV. [Journal Article; Research Support, Non-U.S. Gov’t; Review]. 2018 2018-10-01;98(4):1911–41.

  32. Gonzalez FJ, Xie C, Jiang C. The role of hypoxia-inducible factors in metabolic diseases. NAT REV ENDOCRINOL. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov’t; Review]. 2019 2018-12-01;15(1):21–32.

  33. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J CLIN INVEST. [Journal Article; Review; Research Support, N.I.H., Extramural]. 2017 2017-01-03;127(1):1–4.

  34. Stephenson C, Mohabbat A, Raslau D, Gilman E, Wight E, Kashiwagi D. Management of Common Postoperative Complications. MAYO CLIN PROC. [Journal Article; Review; Video-Audio Media]. 2020 2020-11-01;95(11):2540-54.

  35. O Mara SK. Management of Postoperative Fever in Adult Cardiac Surgical Patients. Dimensions of Critical Care Nursing. [Journal Article]. 2017 2017-05-01;36(3):182–92.

  36. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. NATURE. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov’t; Review]. 2017 2017-02-09;542(7640):177–85.

  37. Gálvez I, Martín-Cordero L, Hinchado MD, Ortega E. β2 Adrenergic Regulation of the Phagocytic and Microbicide Capacity of Circulating Monocytes: Influence of Obesity and Exercise. NUTRIENTS. [Journal Article]. 2020 2020-05-16;12(5):1438.

  38. Reilly SM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. NAT REV ENDOCRINOL. [Journal Article; Review]. 2017 2017-11-01;13(11):633–43.

  39. Hirt PA, Castillo DE, Yosipovitch G, Keri JE. Skin changes in the obese patient.J AM ACAD DERMATOL. [Journal Article; Review]. 2019 2019-11-01;81(5):1037–57.

  40. Garibaldi RA, Brodine S, Matsumiya S, Coleman M. Evidence for the non-infectious etiology of early postoperative fever. Infect Control. [Journal Article; Research Support, U.S. Gov’t, P.H.S.]. 1985 1985-07-01;6(7):273–7.

  41. de Almeida AN, Marino R, Aguiar PH, Teixeira MJ. Postoperative fever after hemispherectomy: The role of non-infectious factors.Seizure. [Journal Article]. 2006 2006-07-01;15(5):340–3.

Download references

Acknowledgements

We thank American Journal Experts (https://www.aje.cn/#) for editing the language of a draft of this manuscript.

Funding

This study did not receive any funding.

Author information

Authors and Affiliations

Authors

Contributions

Shen, Wang, Du, Xiong and Zhao conceived, designed, and supervised the study. Ruan, Yang, Chai, Dai, Yang, and Cai drafted the manuscript. Zhou, Mei, Zheng, Xu, Guo, Lei, Chen, Yue collected the data. Wang, Zhao, Liu, Chen and Chai performed data analysis and visualization. All authors contributed to the article and approved the submitted version.

Corresponding authors

Correspondence to Hao Du or Nanxiang Xiong.

Ethics declarations

Ethics approval and consent to participate

The ethics committee of Wuhan children’s hospital has approved the retrospective study (2022R056-E01). All methods in our study were performed in accordance with the relevant guidelines and regulations.

Informed consent

Patient consent was not required for this retrospective analysis of de-identified Medicare data under the supervision of the ethics committee of Wuhan children’s hospital.

Consent for publication

Not applicable.

Competing interests

Authors associated with this submission have no financial conflicts of interest to disclose.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shen, L., Wang, M., Zhao, J. et al. Study on the relationship between obesity and complications of Pediatric Epilepsy surgery. BMC Pediatr 23, 142 (2023). https://doi.org/10.1186/s12887-023-03948-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-023-03948-9

Keywords